John Overdeck’s Takeda Pharmaceutical TAK Stock Holding History

John Overdeck’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.79M	Buy	485,733 +174,033	+56%	+$2.88M	0.01%	1721
2026 Q1	$5.77M	Buy	+311,700	New	+$5.47M	﹤0.01%	1846
2024 Q1	–	Sell	-33,550	Closed	-$479K	–	3380
2023 Q4	$479K	Sell	33,550 -64,678	-66%	-$918K	﹤0.01%	2485
2023 Q3	$1.52M	Buy	98,228 +1,815	+2%	+$28.1K	﹤0.01%	1647
2023 Q2	$1.51M	Hold	96,413	–	–	﹤0.01%	1687
2023 Q1	$1.59M	Buy	96,413 +16,013	+20%	+$255K	﹤0.01%	1554
2022 Q4	$1.25M	Buy	+80,400	New	+$1.12M	﹤0.01%	1580
2020 Q3	–	Sell	-42,325	Closed	-$759K	–	3543
2020 Q2	$759K	Buy	+42,325	New	+$760K	﹤0.01%	1715
2020 Q1	–	Sell	-92,370	Closed	-$1.82M	–	3803
2019 Q4	$1.82M	Buy	+92,370	New	+$1.77M	0.01%	1666

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

John Overdeck's TAK Position: Q2 2026 in Review

John Overdeck increased its Takeda Pharmaceutical (TAK) stake by 56% in Q2 2026, buying an estimated $2.88M and bringing the position to 485,733 shares worth $7.79M. The position accounts for 0.01% of the portfolio, ranked #1721.

John Overdeck first reported a position in TAK in Q4 2019 and has held it in 9 quarters since. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

John Overdeck held 485,733 shares of Takeda Pharmaceutical worth $7.79M as of Q2 2026.
John Overdeck bought 174,033 Takeda Pharmaceutical shares in Q2 2026, an estimated $2.88M.
Takeda Pharmaceutical made up 0.01% of John Overdeck's portfolio in Q2 2026, its #1721 holding.
John Overdeck first reported a position in Takeda Pharmaceutical in Q4 2019 and has held it in 9 quarters since.
375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.